Prestige Consumer Healthcare Inc (PBH)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$47.57

Buy

$48.14

arrow-up$0.25 (+0.53%)

Prices updated at 12 Jun 2026, 21:10 EDT

Prices minimum 15 mins delay

Prices in USD

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), D ...

S&P 500

0.5%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Ronald M. Lombardi

CEO

Mr. Ronald M. Lombardi

Most recent earnings

31 Mar 2026

Fiscal year end

31 Mar 2026

Employees

890

Head office

660 White Plains Road

Tarrytown

United States

10591

+1 914 524-6800

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Celeste A. Clark, PhD Independent Director	0.11m
Mr. John E. Byom Lead Independent Director	0.13m
Ms. Dawn M. Zier Independent Director	0.12m
Ms. Sheila A. Hopkins Independent Director	0.10m
Ms. Christine Sacco Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer	0.66m
Mr. Ronald M. Lombardi Chairman of the Board, President and Chief Executive Officer	1.00m
Mr. James C. D’Arecca Independent Director	0.12m
Mr. John F. Kelly Independent Director	0.04m
Mr. William C. P'Pool Senior Vice President, General Counsel and Corporate Secretary	0.55m
Mr. Jeffrey Zerillo Executive Vice President, Operations	0.37m
Mr. Adel Mekhail Executive Vice President, Marketing and Sales	0.53m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	7,388,490
Vanguard Group Inc	5,388,758
BlackRock Fund Advisors	5,169,570
Ariel Investments, LLC	4,274,326
iShares Core S&P Small-Cap ETF	2,868,079

Director dealings

Date chevron-l-regular chevron-r-regular	Action
28 Nov 2025	-
01 Dec 2025	-
25 Nov 2025	-
05 Aug 2025	-
05 Aug 2025	-
05 Aug 2025	-
05 Aug 2025	-
05 Aug 2025	-
07 May 2025	-
07 May 2025	-
07 May 2025	-
07 May 2025	-
05 May 2025	-
05 May 2025	-
07 May 2025	-
05 May 2025	-
05 May 2025	-
05 May 2025	-
05 May 2025	-
05 May 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.